Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
2002 Feb;133(2):167-70
This material is supplied for in-vitro laboratory research by qualified professionals
Type of study: non-rct in vitro Number of citations: 15 Year: 2023 Authors: Ying-Yin Zhu, Wuqing Xiao, Wanling Zhong, Chen Xi, Jinhong Ye, Qing Zhang, Huichao Wu, Shouying Du Journal: International journal of pharmaceutics Journal ranking: Q1 Key takeaways: The combined system of Cur-Lips and skin-penetrating peptide TD-1 effectively promotes skin penetration and has great potential for melanoma prevention and treatment
In the United States, research peptides like BPC-157 and TB-500 are sold for laboratory and preclinical use only they are not approved by the FDA for human administration or therapeutic use
US$ 22.19
US$ 24.00
US$ 24.12
US$ 22.48
US$ 22.65
US$ 28.94
